Insider Buying Activity Uncovered - 7 Stocks On The Rise

Insider Activity Alert If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Tiny Lithium Stock Surge!]( t miss out on this tiny stock poised to surge in a massive $183B market opportunity! [Get the Free Report]( --------------------------------------------------------------- December 13, 2023 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [The New Epicenter for Lithium!]( company makes big acquisition in new epicenter of Lithium supply for EV's! [Get Symbol]( --------------------------------------------------------------- [EyePoint Pharmaceuticals]( Ticker: [EYPT]( Recent Price: $19 Average Analyst Price Target: $41.00 (100.00%) Market Cap: $705.13M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 526,315 $9,999,995 2 Days Ago >10% Owner Informative Buy Non Open Market Buy 1,919,057 $41,874,151 8 Days Ago Recent Analyst Action: Zegbeh Jallah, analyst at Capital One Financial, reiterates coverage on [EyePoint Pharmaceuticals (EYPT)]( in the Healthcare sector with a Buy rating and a price target of $44 (2 days ago). Here are 3rd party ratings for [EYPT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 24% (60 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Musk: My new robots could be bigger than Tesla]( No one can deny Elon Musk is a visionary. But has he finally gone too far? [>>See the shocking future of AI here<<]( --------------------------------------------------------------- [BRC]( Ticker: [BRCC]( Recent Price: $4.13 Average Analyst Price Target: $5.75 (39.23%) Market Cap: $898.73M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 186,440 $770,000 2 Days Ago Recent Analyst Action: Bill Chappell, analyst at Truist Financial, reiterates coverage on [BRC (BRCC)]( in the Real Estate sector with a Hold rating and a price target of $5 (3 weeks ago). Here are 3rd party ratings for [BRCC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 32% (170 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Hamilton Insurance Group, Ltd. Class B]( Ticker: [HG]( Recent Price: $15.29 Average Analyst Price Target: $19.40 (27.53%) Market Cap: ― Role Transaction Description No. of Shares Amount Date Director Informative Buy Buy 10,077 $154,078 2 Days Ago Recent Analyst Action: Michael Zaremski, analyst at BMO Capital, reiterates coverage on [Hamilton Insurance Group, Ltd. Class B (HG)]( in the Financial sector with a Buy rating and a price target of $18 (6 days ago). Here are 3rd party ratings for [HG](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Top 11% (27 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [Catalyst Pharma]( Ticker: [CPRX]( Recent Price: $13.35 Average Analyst Price Target: $23.30 (89.14%) Market Cap: $1.47B Role Transaction Description No. of Shares Amount Date VP, Treasurer and CFO Informative Buy Non Open Market Buy 8,464 $113,000 2 Days Ago Recent Analyst Action: Joon Lee, analyst at Truist Financial, reiterates coverage on [Catalyst Pharma (CPRX)]( in the Healthcare sector with a Buy rating and a price target of $25 (1 month ago). Here are 3rd party ratings for [CPRX](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 25% (62 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Flywire]( Ticker: [FLYW]( Recent Price: $21.90 Average Analyst Price Target: $34.00 (54.34%) Market Cap: $2.66B Role Transaction Description No. of Shares Amount Date President & COO Informative Buy Buy 4,561 $99,898 2 Days Ago Recent Analyst Action: Andrew Harte, analyst at BTIG, reiterates coverage on [Flywire (FLYW)]( in the Technology sector with a Buy rating and a price target of $33 (6 days ago). Here are 3rd party ratings for [FLYW](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 46% (135 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The AI Gold Rush: Win With The AI Pickaxe]( the AI Pickaxe to find 4 under the radar AI companies poised for a gold rush. [>> Win The AI Game With The Pickaxe <<]( --------------------------------------------------------------- [Westrock Coffee]( Ticker: [WEST]( Recent Price: $9.76 Average Analyst Price Target: $12.33 (12.70%) Market Cap: $853.10M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 9,825 $95,900 2 Days Ago Recent Analyst Action: Matthew Smith,, analyst at Stifel Nicolaus, reiterates coverage on [Westrock Coffee (WEST)]( in the Consumer Defensive sector with a Buy rating and a price target of $11 (1 month ago). Here are 3rd party ratings for [WEST](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Top 7% (17 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Olema Pharmaceuticals]( Ticker: [OLMA]( Recent Price: $12.45 Average Analyst Price Target: $24.80 (103.45%) Market Cap: $626.57M Role Transaction Description No. of Shares Amount Date CH. OPERATING & FINANCIAL Off Informative Buy Buy 5,638 $70,200 2 Days Ago Recent Analyst Action: Sam Slutsky, analyst at LifeSci Capital, reiterates coverage on [Olema Pharmaceuticals (OLMA)]( in the Healthcare sector with a Buy rating and a price target of $26 (1 week ago). Here are 3rd party ratings for [OLMA](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 24% (60 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [New EV Lithium Player?]( company surges over 178% after recent acquisition in new Lithium epicenter! [See Report]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software